Objective To determine the relationship between white matter hyperintensities (WMH) presumed to indicate disease of the cerebral small vessels, temporal lobe atrophy, and verbal memory deficits in Alzheimer disease (AD) and other dementias.
White matter hyperintensities (WMH) are a measure of brain frailty commonly coincident with Alzheimer disease (AD), presumed to represent damage to the cerebral small vessels. 1 While often shown to decrease attention, executive function, and psychomotor processing speed, 2 WMH are also associated with memory deficits in AD 3, 4 and in vascular cognitive impairment (VCI) due to stroke. 5 The well-replicated effects of WMH on the frontal lobe suggest that the effect of WMH on memory may occur secondarily, as a consequence of poorer strategic information processing 6 ; however, recent studies describe relationships between WMH and disproportionate atrophy of cortical and subcortical temporal lobe structures. 3, [7] [8] [9] Those findings suggest that WMH might also have a more primary effect on memory systems. 10 Notwithstanding the effect of WMH on strategic information processing that influences memory performance, 6 consideration of an independent primary contribution of WMH to the learning and memory deficits often considered to be pathognomonic of AD is warranted. Therefore, this study evaluates the relationship between WMH and poorer verbal memory function, hypothesizing an indirect effect that is mediated by left temporal lobe atrophy, both in participants with and without AD.
Methods

Study design
The volume of WMH (independent variable) was used as a measure of small vessel disease severity. 1 A proof-ofprinciple sample was designed specifically to include representative strata of minimal to extensive WMH, including those with and without AD. A consecutive sample of tertiary care cases presenting to a memory clinic was used to confirm the relevance of the hypothesized pathway. Participants were included if they had an MRI adequate for processing, and if they completed the memory assessment.
Proof-of-principle sample
This cross-sectional sample was designed to elucidate relationships between subcortical ischemic vascular disease and cognitive performance. Five groups of participants (table 1) , aged 50-85, were recruited between 2007 and 2013: (1) patients with extensive WMH (≥4 focal lesions each ≥5 mm in diameter or periventricular WMH extending at least 5 mm from the ventricular border consistent with Fazekas scale periventricular hyperintensity score ≥2) who presented to a stroke prevention clinic within 3 months of TIA with no residual physical symptoms, (2) patients with AD who had minimal WMH (Fazekas scale periventricular hyperintensity score ≤1 and ≤3 focal hyperintensities none of which were ≥3 mm in diameter), (3) patients with AD who had extensive WMH (as per same criteria above), (4) healthy elderly volunteers similar in age to the former groups with minimal WMH (as per same criteria above), and (5) patients with symptomatic coronary artery disease without a neurologic diagnosis recruited from a cardiac rehabilitation clinic. 11 All participants undertook MRI at 3.0T for the purpose of this study, were fluent in English, had hearing adequate for cognitive testing, and had Mini-Mental State Examination (MMSE) score >19. Participants with other neurologic diagnoses or those presenting with cortical infarcts or cortical hyperintensities (>3 hyperintense foci, or any lesion >3 mm in diameter) were excluded. Participants with unstable medical conditions or other neurologic or psychiatric histories were excluded, with the exception of mild depressive symptoms.
Confirmation sample
Baseline cross-sectional data were used from the Sunnybrook Dementia Study, an observational study of prospectively collected (1992-2014) consecutive patients from a real-world tertiary care clinic that includes non-mutually exclusive diagnoses of dementia or mild cognitive impairment (MCI) due to AD, VCI or other/mixed causes, and healthy elderly controls. 12 Cortical stroke and other neurodegenerative signs were not excluded from this sample, in order to determine if the effects of WMH on memory were robust and generalizable.
Standard protocol approvals, registrations, and patient consents This study received approval from an institutional ethical standards committee. Written informed consent was obtained from all patients, or from their substitute decision makers with patient assent. The Sunnybrook Dementia Study is registered at clinicaltrials.gov (NCT01800214).
Assessments Verbal memory assessment
Verbal memory was assessed using the California Verbal Learning Test (CVLT); the proof-of-principle sample used the 2nd edition, while the confirmation sample used the 1st edition. In both versions, a list of 16 words is read 5 times, the participant is asked to recall the list immediately after each Glossary AD = Alzheimer disease; BPF = brain parenchymal fraction; CAA = cerebral amyloid angiopathy; CI = confidence interval; CVLT = California Verbal Learning Test; ICC = intraclass coefficient; LE = Lesion Explorer; LTL = left temporal lobe; MCI = mild cognitive impairment; MMSE = Mini-Mental State Examination; SABRE = Semi-Automatic Brain Region Extraction; VCI = vascular cognitive impairment; WMH = white matter hyperintensities.
trial, and the total number of words recalled correctly over the 5 learning trials is recorded as a measure of verbal learning. The CVLT also assesses to what degree different learning strategies are used. The word list is divided into 4 categories, and the degree to which participants group words into categories during recall is recorded as "semantic clustering," a strategic information processing strategy that engages frontal-subcortical circuits. 13, 14 After a distractor task and a 20-minute delay, the participant is asked to recall the list freely from memory, which is recorded as delayed free recall. Next, recognition memory is assessed in a forced choice trial wherein participants discriminate between words that were on the list from those that were not. The number correctly retained is compared to those incorrectly guessed. Providing the words as memory cues subverts retrieval demands and therefore offers a more precise measure of the inability to retain information.
MRI methodology and processing
Brain MRI was obtained at 3.0T (Discovery MR750; General Electric, Cleveland, OH) in the proof-of-principle sample and at 1.5T (Signa, General Electric) in the confirmation sample (e-Methods, links.lww.com/WNL/A159). Images were processed using Lesion Explorer (LE; sabre.brainlab.ca; figure 1 ), a comprehensive, highly reliable (global intraclass coefficient [ICC] 0.99; regional ICC 0.98; Similarity Index 0.97; scanrescan reliability for all tissue types ICC >0.9) and previously validated (LE vs kNN ICC 0.97, LE vs Age-Related White Matter Change scale r = 0.86) tri-feature segmentation and parcellation procedure for regionalized brain volumetrics. [15] [16] [17] Briefly, segmentation utilizes coregistered T1, proton density, and T2 images to obtain regionalized volumes of normalappearing gray matter (NAGM), normal-appearing white matter (NAWM), ventricular CSF (vCSF) and sulcal CSF (sCSF), WMH, and subcortical silent infarcts (lacunes). Skull and other nonbrain structures were removed with Brain-Sizer, a LE component, to obtain supratentorial volume (total intracranial capacity), including subarachnoid CSF immediately below the dura mater. The tissue segmentation fits localized voxel intensities to 4 Gaussian curves and the Semi-Automatic Brain Region Extraction (SABRE) component of LE parcellates the brain into standardized volumes of interest including the left temporal lobe (LTL). 16 The third component of LE segments WMH using proton density/T2 sequences and further segments lacunar-like infarcts within each hyperintensity using information from the initial T1 segmentation. Thus, WMH volume was obtained. The result is a personalized segmentation map, which is ideally suited to assess regional tissue volumes unconfounded by atrophy or WMH. Atrophy was inferred as the brain-parenchymal fraction (BPF) calculated from tissue class estimates specifically within the LTL as delineated by SABRE (figure 1):
The volumes of WMH and lacunes were not included in the denominator to avoid inflating estimates of the association of WMH volume with atrophy, or in the numerator to avoid inflating estimates of healthy tissue.
Clinical diagnoses
To identify dementia or MCI due to AD, or VCI, clinical diagnoses were made, by consensus of 2 independent clinicians, using prevailing criteria, behavioral neurology assessments, clinical reports of SPECT and MRI scans, the MMSE, and the Dementia Rating Scale. MCI was diagnosed by Petersen-Albert criteria. 18, 19 McKhann criteria 20, 21 were used to diagnose AD, also compatible with National Institute of Neurological and Communicative Disorders and StrokeAlzheimer's Disease and Related Disorders Association criteria. 20 VCI was diagnosed according to clinical 22 and National Institute of Neurological Disorders and StrokeAssociation Internationale pour la Recherche en l'Enseignement en Neurosciences research criteria. 23 Other diagnoses were made by prevailing clinical criteria (e-references, links. lww.com/WNL/A160).
Statistical methods
WMH volumes were log-transformed. To test the mediation hypotheses, a bias-corrected bootstrapping procedure was used for inferential estimation of indirect effects. The method makes no assumptions about normality in the sampling distribution and offers better control of type I error compared to other methods such as the Sobel method. 24, 25 Confidence intervals (CIs) were estimated using 10,000 replications and Abbreviations: AD = Alzheimer disease; CAD = coronary artery disease; TIC = total intracranial capacity; WMH = white matter hyperintensity.
indirect effects were considered significant when the 95% bias corrected bootstrapped interval did not contain zero.
It was hypothesized that a serial mediation effect runs from WMH to left temporal atrophy 3, 8, 9 to verbal learning to verbal recall (the left temporal lobe was examined due to correlation with verbal memory in previous studies). 26 This indirect effect was estimated by multiplying the coefficients from 3 sequential linear regression models representing the pathway links (a × b × c). The models simultaneously estimate 2 shorter pathways, from WMH to left temporal atrophy to verbal recall (a × b 2 ), and from WMH to verbal learning to verbal recall (a 2 × c), and the direct effect between WMH and verbal recall adjusted for the indirect
Total intracranial capacity, age, years of formal education, and sex were added to the model as covariates, regressed at once on mediators and outcomes. Path coefficients were estimated in SPSS (version 22; SPSS Inc., Chicago, IL) using the PRO-CESS macro. 27 To determine the scope of relevance, sensitivity analyses were carried out in those who met and did not meet clinical criteria for possible or probable AD, in those who did not meet clinical criteria for VCI, and in women and men separately. To determine if imaging and cognitive measures were specific as mediators, substitutions into the hypothesized pathway were tested; verbal learning with semantic clustering (a component of strategic information processing), left temporal atrophy with atrophy of other lobes (to determine if the results might be explained, for instance, by frontal atrophy), and delayed free recall with recognition memory (to probe more AD-specific memory deficits).
Results
Proof-of-principle sample Volumes of WMH differed between groups (figure 2A), as did the BPF in the left temporal lobe; the group with extensive WMH but without AD had temporal lobe atrophy comparable to that of the AD groups (figure 2B), and the AD group with In the path model, just one indirect pathway was significant as hypothesized, wherein WMH volume was associated with poorer verbal recall, mediated serially by left temporal lobe atrophy and verbal learning ( figure 3A ). There was no direct effect independent of the hypothesized pathway, nor were any other pathways significant.
Confirmation sample
Of 815 records, 729 patients provided a CVLT and demographic data, and 702 of those had MRI sufficient for processing. For a breakdown of the sample by diagnosis and correlations between MRI measures, see tables e-1, e-2, and e-3 (links.lww.com/WNL/A160). Total WMH volume was inversely correlated with left temporal lobe BPF (r = −0.385, p < 0.001) and with verbal learning (r = −0.201, p < 0.001) and recall (r = −0.187, p < 0.001). WMH in each lobe were associated with left temporal atrophy (table e-2), justifying the use of the whole brain measure in mediation models. Correlations between total WMH volume and each lobar atrophy measure are presented in table e-3, showing the strongest correlations in the temporal lobes.
In the path model, only the hypothesized serial mediation pathway was significant, as in the proof-of-principle sample. The other indirect pathways were not significant, and the direct relationship between WMH and verbal recall was attenuated by the indirect effects ( figure 3B ).
Sensitivity analyses
Substituting verbal learning with semantic clustering (n = 655) revealed the identical serial mediation pathway between WMH and long-delayed free recall; however, in this model, a significant a × b 2 pathway was also observed, indicating that effects of WMH on verbal learning other than semantic clustering also had a significant effect on verbal recall (figure e-1A, links.lww.com/wnl/A161).
Substituting left temporal atrophy with left frontal atrophy (n = 702) demonstrated no significant effects on verbal When delayed free recall was replaced with recognition memory (n = 689), the hypothesized indirect pathway was observed (a × b × c = −1.82%, 95% CI −2.64% to −1.11%). A second indirect pathway was also significant (a × b 2 = −0.69%, 95% CI −1.40% to −0.23%), indicating that processes other than verbal learning also contributed to deficits in recognition memory related to WMH (i.e., forgetting learned information after a delay).
Subgroup analyses
For subgroup analyses, the confirmation sample was grouped into patients who met clinical criteria for AD and those who did not, and patients who met clinical criteria for VCI and those who did not (table 2) . The AD and VCI subgroups were not mutually exclusive (93 patients met both criteria).
The hypothesized serial mediation pathway was significant in subgroups with (figure e-1C, links.lww.com/wnl/A161) and without AD (figure e-1D, links.lww.com/wnl/A161), and in a subgroup not diagnosed clinically with VCI (a × b × c = −0.680, 95% CI −1.010 to −0.332 words). The identical indirect pathway was significant in men (a × b × c = −0.498, 95% CI −0.885 to −0.188 words, n = 324) and women (a × b × c = −0.802, 95% CI −1.220 to −0.431 words, n = 378).
In a subgroup with AD without VCI, when substituting delayed free recall with recognition memory (n = 263), only the hypothesized serial mediation pathway was significant, indicating that WMH contributed to recognition memory specifically via temporal lobe atrophy and verbal learning in AD (figure e-1E, links.lww.com/wnl/A161).
Post hoc model
To discount the notion that an underlying factor correlated with both WMH and left temporal atrophy might have led to a spurious path effect, an alternative model was tested in which left temporal lobe atrophy leads to WMH volume, which leads to verbal learning and verbal recall.
No evidence for this pathway was found (mediation effect −0.190, 95% CI −1.017 to 0.533 words), indicating that the mediation effect is specific to the hypothesized sequential order. Verbal recall (words) 1.8 ± 2.5 6.6 ± 4. Abbreviations: AD = dementia or mild cognitive impairment thought to be attributable to Alzheimer disease; BPF = brain parenchymal fraction; CVLT = California Verbal Learning Test; TIC = total intracranial capacity; VCI = dementia or cognitive impairment thought to be attributable to vascular lesions.
Values are mean ± SD unless noted otherwise. a Categorical diagnoses are not mutually exclusive (mixed diagnoses were included in this sample).
Discussion
In 2 independent samples, WMH were related to poorer verbal memory, confirming a distinct underappreciated contribution to dementia. 4 In the first sample, cortical stroke was excluded to infer specific effects of subcortical small vessel disease, a common co-pathology in AD that lowers the dementia threshold. 28 The effect of WMH was confirmed in an unselected, heterogeneous, consecutive, real-world case series, including patients across spectra of common, mixed, and rarer dementia syndromes. This validation strategy is conservative since significance rose above statistical noise introduced by multiple intervening pathologies, indicating robust effects broadly relevant across neurodegenerative disorders.
WMH volume was associated particularly with temporal lobe atrophy, and its effect on memory was due to this relationship; WMH volume was associated with poorer verbal memory only insofar as temporal lobe atrophy was seen. Previously, effects of WMH may have been underestimated because they are eclipsed when controlling for atrophy; however, here we show that WMH contribute to that atrophy. The results clarify the network effects of WMH underlying verbal memory deficits; however, further effects of strategically located lesions can contribute by interrupting circuits important for memory performance regardless of their size. 29 Verbal memory deficits related to WMH volume arose at the learning stage, although additional effects on delayed free recall were seen in those without AD, likely reflecting effects of WMH on retrieval of learned information. Temporal atrophy mediated the observed effects of WMH on learning, including reduced use of semantic clustering, a strategy consistent with previously observed effects of WMH on memory performance via information processing/executive function. 6 Although semantic clustering acted as a mediator, additional effects of WMH on verbal recall were seen that could not be explained by this executive strategy.
Often WMH have been considered inconsequential in AD, in part because their contribution to memory deficits has not been understood. In AD, WMH contributed, via the hypothesized serial mediation pathway, to variance underlying recognition memory, a sensitive and specific neuropsychological sign of AD, even though no direct effects of WMH on recognition memory were observed. Since WMH contributed to the identical memory deficits as the more canonical features of AD, the present in vivo findings add to the evidence that WMH can constitute a core feature of the AD dementia syndrome. Autopsy studies confirm that lateonset dementia is often a product of multiple synergistic pathologies. 30 In a recent series of those aged 90+, the presence of ischemic findings contributed additively to the likelihood of a dementia diagnosis, increasing the risk 4-fold above that attributable to amyloid or tau pathology alone. 31 Even "pure" autosomal dominant AD cases show increased propensity for WMH, mostly likely due to cerebral amyloid angiopathy (CAA) in those cases that precedes the dementia syndrome. 32 Among those clinically diagnosed with AD in life, at least 50% will have significant small vessel disease at autopsy. 33, 34 On pathology, WMH are often related to damage to the small cerebral vessels, which can arise heterogeneously with atherosclerosis, arteriolosclerosis, venous collagenosis and vessel tortuosity related to vascular risk factors and remodeling phenomena, CAA, demyelination and axonal loss, bloodbrain barrier disruption, or deterioration of the ventricular ependymal lining. [35] [36] [37] Although these causes cannot be differentiated here, collectively they may lead to diffuse chronic hypoperfusion injury to the temporal lobe directly, or to atrophy secondary to disruption of temporal lobe network connectivity. 29 Therefore, strategies to protect the small vessels, prevent insults to the white matter, or manipulate downstream molecular pathways that lead to temporal lobe atrophy might be necessary to prevent and treat many AD cases. 38, 39 As a limitation, few cognitively healthy controls were included, limiting generalizability to "normal aging"; however, since multiple dementias were included, the validation approach was conservative with respect to our main objectives. As a further limitation, fluid biomarker confirmation of AD was not available, precluding assessment of "additive" effects of WMH with other AD-related markers. 29, 40 Analyses included only patients with complete data, possibly introducing bias at imaging (e.g., motion in the scanner), or cognitive testing. The lower sensitivity of MRI at 1.5T to WMH may have contributed to different numerical estimates between the proof-of-principle and confirmation samples; regardless, the identical hypothesized pathway was validated. The results show that WMH-based anatomical network disruption contributes to verbal memory deficits across dementia syndromes, implicating small vessel disease as an important underlying etiology. The effect of white matter hyperintensities on verbal memory
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